Pressure BioScience (OTCQB: PBIO) is a leader in the
development and sale of broadly enabling, pressure-based instruments,
consumables, and platform technology solutions to the worldwide biotechnology,
biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage
industries. On April 29, PBIO announced its entrance into a binding letter of
intent to acquire Cannaworx Inc. (http://ibn.fm/TfZgu).
An article discussing the company reads, “The merged entity, equipped with an
extensive intellectual property portfolio utilizing a proprietary pressure
platform, nanotechnology and advanced delivery systems, plans to disrupt a
number of major world markets. These include the international cosmetics
market, projected to reach $758 billion by 2025 (http://ibn.fm/5N4vZ); the global agricultural technology
and products market, projected at $729 billion by 2023 (http://ibn.fm/XLNAf); the global
biopharmaceuticals market, expected to reach $389 billion by 2024 (http://ibn.fm/7VJpy); as well as
the U.S. hemp-derived CBD market, anticipated to reach $23.7 billion by
2023 (http://ibn.fm/4bLkg).
. . . Cannaworx’s diverse portfolio of products and intellectual property was
developed by its founders Bobby Ghalili, DMD, and Adrienne Denese, MD, PhD.
Ghalili and Denese bring extensive medical expertise and product innovation
into the newly combined public company. They have an impressive multiyear track
record of developing and selling personal-care and nutrition products.”
To view the full article, visit http://ibn.fm/rNR29
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale
of innovative, broadly enabling, pressure-based solutions for the worldwide
life-sciences industry. The company’s products are based on the unique
properties of both constant (i.e., static) and alternating (i.e.,
pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented,
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
PBIO’s primary focus is in the development of PCT-based products for biomarker
and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil and plant biology, forensics and
counter-bioterror applications. Additionally, major new market opportunities
have emerged in the use of its pressure-based technologies in the following
areas: (1) the use of its recently acquired, patented technology from BaroFold
Inc. (the “BaroFold” technology) to allow entry into the biopharma contract
services sector, and (2) the use of its recently patented, scalable,
high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i)
create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and
water) and (ii) prepare higher-quality, homogenized, extended shelf-life or
room-temperature, stable, low-acid liquid foods that cannot be effectively
preserved using existing nonthermal technologies. For more information, visit
the company’s website at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates
relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer excellent
growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment